Snk Nutraceutical Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 03-07-2024
- Paid Up Capital ₹ 1.30 M
as on 03-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 03-07-2024
- Revenue 3.33%
(FY 2022)
- Profit 104.08%
(FY 2022)
- Ebitda -438.07%
(FY 2022)
- Net Worth 0.29%
(FY 2022)
- Total Assets 9549.12%
(FY 2022)
About Snk Nutraceutical
The Corporate was formerly known as Konark Boards Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 1.30 M.
The company currently has active open charges totaling ₹1.00 Cr.
Jyotika Uppal and Saurabh Gulati serve as directors at the Company.
- CIN/LLPIN
U74900DL2007PTC162552
- Company No.
162552
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Snk Nutraceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotika Uppal  | Director | 28-Feb-2014 | Current |
| Saurabh Gulati | Director | 24-Apr-2007 | Current |
Financial Performance of Snk Nutraceutical.
Snk Nutraceutical Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.33% increase. The company also saw a substantial improvement in profitability, with a 104.08% increase in profit. The company's net worth moved up by a moderate rise of 0.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snk Nutraceutical?
In 2018, Snk Nutraceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ssnc Manufacturing Private LimitedActive 1 year 9 monthsJyotika Uppal and Saurabh Gulati are mutual person
- Ssnc India Private LimitedActive 1 year 11 months
Jyotika Uppal and Saurabh Gulati are mutual person
- Ssnc Distribution Private LimitedActive 1 year 11 months
Jyotika Uppal and Saurabh Gulati are mutual person
- Kanishk Overseas Private LimitedActive 10 years 4 months
Jyotika Uppal and Saurabh Gulati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Limited Creation Date: 09 Mar 2012 | ₹5.00 M | Open |
Karnataka Bank Ltd. Creation Date: 09 Mar 2012 | ₹5.00 M | Open |
How Many Employees Work at Snk Nutraceutical?
Unlock and access historical data on people associated with Snk Nutraceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snk Nutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snk Nutraceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
